Harmony Biosciences Holdings, Inc. (HRMY) Insider Trading -- Recent Executive & Director Transactions

15 insiders reported 76 Form 4 transactions for Harmony Biosciences Holdings, Inc. (HRMY) over the past 18 months (most recent 2026-05-18). Recent activity: Budur Kumar (CHIEF MEDICAL OFFICER) Sell 8,882 shares, Budur Kumar (CHIEF MEDICAL OFFICER) Buy 18,750 shares, Zaeske Adam H. (CHIEF COMMERCIAL OFFICER) Buy 7,500 shares, Zaeske Adam H. (CHIEF COMMERCIAL OFFICER) Sell 3,173 shares, Kapadia Sandip (CHIEF FINANCIAL OFFICER) Sell 3,746 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-05-18Budur KumarCHIEF MEDICAL OFFICERSell8,882$282,714
2026-05-18Budur KumarCHIEF MEDICAL OFFICERBuy18,750$0
2026-04-09Zaeske Adam H.CHIEF COMMERCIAL OFFICERBuy7,500$0
2026-04-09Zaeske Adam H.CHIEF COMMERCIAL OFFICERSell3,173$87,638
2026-01-28Kapadia SandipCHIEF FINANCIAL OFFICERSell3,746$139,164
2026-01-26Budur KumarCHIEF MEDICAL OFFICERSell1,372$50,517
2026-01-26Serafin AndrewCHIEF STRATEGY OFFICERSell1,116$41,091
2026-01-26Serafin AndrewCHIEF STRATEGY OFFICERBuy2,600$0
2026-01-26Serafin AndrewCHIEF STRATEGY OFFICERSell1,126$41,459
2026-01-26Budur KumarCHIEF MEDICAL OFFICERBuy2,188$0
2026-01-26Budur KumarCHIEF MEDICAL OFFICERSell1,153$42,453
2026-01-26Budur KumarCHIEF MEDICAL OFFICERBuy2,662$0
2026-01-26Serafin AndrewCHIEF STRATEGY OFFICERBuy2,500$0
2026-01-26Kapadia SandipCHIEF FINANCIAL OFFICERSell2,239$82,440
2026-01-26Kapadia SandipCHIEF FINANCIAL OFFICERBuy4,725$0
2026-01-26Kapadia SandipCHIEF FINANCIAL OFFICERSell2,553$94,001
2026-01-26Dayno Jeffrey M.PRESIDENT, CEOBuy10,500$0
2026-01-26Dayno Jeffrey M.PRESIDENT, CEOSell4,785$176,184
2026-01-26Dayno Jeffrey M.PRESIDENT, CEOBuy13,000$0
2026-01-26Dayno Jeffrey M.PRESIDENT, CEOSell5,654$208,180
2026-01-26Kapadia SandipCHIEF FINANCIAL OFFICERBuy3,813$0
2026-01-20Kapadia SandipCHIEF FINANCIAL OFFICERSell20,961$752,919
2025-12-17Dayno Jeffrey M.PRESIDENT, CEOSell5,933$237,973
2025-12-17Dayno Jeffrey M.PRESIDENT, CEOBuy20,000$164,400
2025-12-17Dayno Jeffrey M.PRESIDENT, CEOSell20,000$802,200

Source: SEC Form 4 filings · as of 2026-05-18